Hangzhou Biotest Biotech Co., Ltd. (688767.SH) Stock Price, Financials & Summary | drillr

Skip to content

Sign in Sign up

Price chart

Aug 20Aug 25Aug 28Sep 2Sep 7Sep 10Sep 15Sep 18

Key dataSep 18, 2026

OpenCNY 37.58

From 52W high−16.98%

Volume4.94M

Market capCNY 5.25B

P/E (TTM)106.6x

P/S (TTM)13.6x

Div yield1.71%

Key dataSep 18, 2026

Open

CNY 37.58

From 52W high

−16.98%

Volume

4.94M

Market cap

CNY 5.25B

ValuationView details →

P/E (Fwd)

—

EV/EBITDA

63.2x

P/E (TTM)

106.6x

RSI (14)

60.8

MomentumView details →

1D Return

−13.65%

YTD Return

—

ValuationView details →

P/E (Fwd)

—

P/E (TTM)

106.6x

EV/EBITDA

63.2x

EV/Sales

10.5x

P/S (TTM)

13.6x

P/B (TTM)

2.3x

ProfitabilityView details →

Gross Margin

46.31%

Net Margin

6.74%

EBITDA Margin

16.64%

ROE (TTM)

1.28%

ROA (TTM)

1.22%

Asset Turnover

0.18x

GrowthView details →

Revenue YoY

−12.15%

EPS YoY

−78.88%

FCF YoY

—

Revenue CAGR 3Y

−38.23%

EPS CAGR 3Y

−63.94%

EBITDA YoY

—

MomentumView details →

1D Return

−13.65%

YTD Return

—

1Y Return

—

RSI (14)

60.8

vs 50D SMA

+9.03%

vs 200D SMA

—

Capital & dividendView details →

Debt/Equity

0.00x

Current Ratio

14.11x

Quick Ratio

13.47x

Div Yield

1.71%

Div Rate

CNY 0.70

Div Growth 1Y

+87.50%

EarningsView details →

EPS (Actual)

—

EPS Surprise

—

Beats (12Q)

—

Next Q EPS Est

—

Avg Surprise (4Q)

—

Rev Surprise

—

Financials snapshotView financials →

Revenue (TTM)

449.50M

Net Income (TTM)

30.31M

Op. CF (TTM)

60.91M

Latest newsMore news →

Botuo Biotech announced at its 2026 interim results briefing that it will seek investment and mergers/acquisitions to open new growth tracks in the medical and health sector.13d ago

Similar companies

Apellis Pharmaceuticals, Inc.APLS Abbisko Cayman Limited02256.HK Erasca, Inc.ERAS CK Life Sciences Int'l., (Holdings) Inc.00775.HK Dianthus Therapeutics, Inc.DNTH PTC Therapeutics, Inc.PTCT Find similar companies →

Latest newsMore news →

Botuo Biotech announced at its 2026 interim results briefing that it will seek investment and mergers/acquisitions to open new growth tracks in the medical and health sector.13d ago